Shenglin Zhang
Key Laboratory Of Standardization For Chinese Herbal Medicine
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mitochondrial-endoplasmic reticulum interactions in lung diseases.
Journal: Cell death & disease
Published: January 08, 2026
Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 04, 2024
A comprehensive review of miR-21 in liver disease: Big impact of little things.
Journal: International immunopharmacology
Published: February 21, 2024
Exploring the effect and mechanism of cucurbitacin B on cholestatic liver injury based on network pharmacology and experimental verification.
Journal: Journal of ethnopharmacology
Published: October 08, 2023
Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways.
Journal: Inflammation
Published: September 14, 2023
A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 13, 2023
The protective effect of forsythiaside A on 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver injury in mice: Based on targeted metabolomics and molecular biology technology.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 10, 2023
CD44-Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3-Mediated Pyroptosis.
Journal: Advanced healthcare materials
Published: September 01, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026